Escalation in vascular access means moving to the safest device that meets the therapy need, not automatically jumping to a PICC or midline. It is about matching the line to the drug, duration, and patient, while minimizing risk.
What escalation really means
Escalation is the process of moving from simpler to more complex vascular access only when clinical needs demand it. It starts with asking what is needed (drug type, frequency, blood draws, duration) and then choosing the least invasive device that can safely deliver that therapy. Escalation therefore may stop at an ultrasound guided peripheral IV or a short peripheral catheter if that option can meet the therapy requirements.
Why escalation is not “PICC by default”
Ordering a PICC simply because “the patient has bad veins” ignores evidence-based device selection and exposes patients to unnecessary central line risks. PICCs carry higher risks of central line associated bloodstream infection, deep vein thrombosis, and procedure complexity compared with many peripheral options. Escalation should occur because central access is required (e.g.,TPN, longterm therapy), not because peripheral attempts were inconvenient.
Why escalation is not “midline by default”
Similarly, midlines should not be placed just because a patient has difficult access or to avoid central line reporting metrics. Midlines are still invasive devices with their own complication profiles (e.g., thrombosis, occlusion, infiltration) and are inappropriate for vesicant, irritant, extreme pH, or highly hyperosmolar solutions. Using midlines indiscriminately can trade “reportable” central line complications for a different, under recognized set of peripheral complications.
Key decision factors before choosing PICC or midline
Before escalating to a PICC or midline, clinicians should systematically consider:
- Infusate characteristics: vesicant vs non‑vesicant, pH, osmolarity.
- Duration: hours–3 days (short peripheral), 4–14 days (consider midline), weeks–months (often PICC or other central access).
- Need for frequent blood draws, hemodialysis, or rapid infusions.
- Patient factors: previous DVT, renal disease, anatomy, goals of care, discharge plans.
This framework often reveals that optimized peripheral IVs or ultrasound guided PIVs can safely meet needs without a PICC or midline. It also supports cases where escalation truly is to a tunneled CVC or port instead of a PICC or midline.
Example device selection focus
A rational escalation algorithm focuses on “right line, right therapy, right time” rather than on any single device. For short courses of nonvesicant antibiotics, a well placed peripheral or midline may be appropriate, for prolonged TPN or vesicant chemotherapy, central access (often a PICC or other central device) is justified. Teaching that “escalation equals PICC or midline” oversimplifies practice and can increase harm, while teaching that escalation equals “minimum device that safely meets the therapy” supports better outcomes and stewardship of invasive lines.
Explore our range of vascular access solutions. Our portfolio allows clinicians to choose the appropriate device for the level of care required. Please contact us today for more information about our products and for a custom quotation.
Health Line International Corp. is not responsible for any errors, omissions, injury, loss, or damage arising from or relating to the use (or misuse) of any information, statements, or conclusions contained in or implied by the contents of this document or any of the source materials. This content is not intended to replace professional medical advice.
References:
Nickel, B. et al., (2024, January/ February) Infusion Therapy Standards of Practice 9th edition. Journal of Infusion Nursing. https://www.ins1.org/publications/infusion-therapy-standards-of-practice/
Thomsen, S. et al., (2024, February 13) Safety and Efficacy of Midline vs Peripherally Inserted Central Catheters Among Adults Receiving IV Therapy. JAMA Network. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814994